Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation

[1]  Ron Edgar,et al.  NCBI gene expression and hybridization array data repository , 2020 .

[2]  Junying Yuan,et al.  Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke , 2020, Proceedings of the National Academy of Sciences.

[3]  K. Newton.  Multitasking Kinase RIPK1 Regulates Cell Death and Inflammation. , 2019, Cold Spring Harbor perspectives in biology.

[4]  G. L. Hamilton,et al.  Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket group. , 2019, Bioorganic & medicinal chemistry letters.

[5]  Adam R. Johnson,et al.  Structure of human RIPK1 kinase domain in complex with GNE684 , 2019 .

[6]  Adam R. Johnson,et al.  RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases , 2019, Cell Death & Differentiation.

[7]  G. Kollias,et al.  A20 prevents inflammasome-dependent arthritis by inhibiting macrophage necroptosis through its ZnF7 ubiquitin-binding domain , 2019, Nature Cell Biology.

[8]  A. Degterev,et al.  Targeting RIPK1 for the treatment of human diseases , 2019, Proceedings of the National Academy of Sciences.

[9]  Michelle C. Schaeffer,et al.  Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase. , 2019, Journal of medicinal chemistry.

[10]  M. Bertrand,et al.  Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation , 2019, Nature Communications.

[11]  C. Sheridan.  Death by inflammation: drug makers chase the master controller , 2019, Nature Biotechnology.

[12]  Martin Eisenacher,et al.  The PRIDE database and related tools and resources in 2019: improving support for quantification data , 2018, Nucleic Acids Res..

[13]  M. Pasparakis,et al.  RIP Kinases in Liver Cell Death, Inflammation and Cancer. , 2019, Trends in molecular medicine.

[14]  S. Henderson,et al.  TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation , 2018, Nature Cell Biology.

[15]  Junying Yuan,et al.  TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging , 2018, Cell.

[16]  Marcus Krüger,et al.  Instant Clue: A Software Suite for Interactive Data Visualization and Analysis , 2018, Scientific Reports.

[17]  Jian Cheng,et al.  Necrostatin-1 Improves Long-term Functional Recovery Through Protecting Oligodendrocyte Precursor Cells After Transient Focal Cerebral Ischemia in Mice , 2018, Neuroscience.

[18]  D. Vučić,et al.  Intracellular regulation of TNF activity in health and disease. , 2018, Cytokine.

[19]  P. A. Harris,et al.  Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers , 2017, Pharmacology research & perspectives.

[20]  M. Aepfelbacher,et al.  p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection , 2017, Nature Cell Biology.

[21]  M. Bertrand,et al.  MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death , 2017, Nature Cell Biology.

[22]  J. Levin,et al.  RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease , 2017, Proceedings of the National Academy of Sciences.

[23]  Junying Yuan,et al.  Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis , 2017, Nature Communications.

[24]  G. Brumatti,et al.  MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death , 2017, Molecular cell.

[25]  A. Degterev,et al.  Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis. , 2017, Trends in pharmacological sciences.

[26]  Michelle C. Schaeffer,et al.  Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases. , 2017, Journal of medicinal chemistry.

[27]  Chuan-Qi Zhong,et al.  RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome , 2017, Nature Communications.

[28]  A. Strasser,et al.  RIPK1 inhibits ZBP1-driven necroptosis during development , 2016, Nature.

[29]  M. Pasparakis,et al.  RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation , 2016, Nature.

[30]  Marco Y. Hein,et al.  The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.

[31]  N. van Bruggen,et al.  RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury , 2016, Cell Death and Differentiation.

[32]  U. Klein,et al.  NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions , 2016, Immunity.

[33]  P. Schirmacher,et al.  NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis , 2015, Cancer cell.

[34]  P. Schirmacher,et al.  NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK 1 Kinase Activity-Mediated Hepatocyte Apoptosis Graphical , 2017 .

[35]  M. Bertrand,et al.  NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling. , 2015, Molecular cell.

[36]  Junying Yuan,et al.  Activation of necroptosis in multiple sclerosis. , 2015, Cell reports.

[37]  P. Vandenabeele,et al.  Necroptosis and its role in inflammation , 2015, Nature.

[38]  I. Dikic,et al.  Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis , 2014, eLife.

[39]  D. Vaux,et al.  TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice , 2014, eLife.

[40]  Jiahuai Han,et al.  RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway , 2014, Nature Immunology.

[41]  M. Bertrand,et al.  RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis , 2014, Nature.

[42]  M. Pasparakis,et al.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis , 2014, Nature.

[43]  M. Pasparakis,et al.  Cutting Edge: RIPK1 Kinase Inactive Mice Are Viable and Protected from TNF-Induced Necroptosis In Vivo , 2014, The Journal of Immunology.

[44]  P. Schirmacher,et al.  Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout , 2014, Cell Death and Differentiation.

[45]  Michelle C. Schaeffer,et al.  Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. , 2014, Journal of immunology.

[46]  M. Bertrand,et al.  MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. , 2014, Cell reports.

[47]  D. Green,et al.  RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3 , 2014, Cell.

[48]  D. Vaux,et al.  RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis , 2014, Cell.

[49]  J. Bertin,et al.  RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition , 2014, Proceedings of the National Academy of Sciences.

[50]  L. Komuves,et al.  Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis , 2014, Science.

[51]  Ling-gang Wu,et al.  Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis , 2013, Nature Cell Biology.

[52]  F. Chan,et al.  Positive and negative phosphorylation regulates RIP1- and RIP3-induced programmed necrosis. , 2013, The Biochemical journal.

[53]  A. Kaser,et al.  Paneth cells as a site of origin for intestinal inflammation , 2013, Nature.

[54]  T. Vanden Berghe,et al.  RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. , 2011, Immunity.

[55]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[56]  Xiaodong Wang,et al.  TNF-α Induces Two Distinct Caspase-8 Activation Pathways , 2008, Cell.

[57]  Alexei Degterev,et al.  Identification of RIP1 kinase as a specific cellular target of necrostatins. , 2008, Nature chemical biology.

[58]  J. Sundberg,et al.  Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis , 2007, Genes and Immunity.

[59]  M. Neurath,et al.  Epithelial NEMO links innate immunity to chronic intestinal inflammation , 2007, Nature.

[60]  T. Luedde,et al.  Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma , 2007 .

[61]  T. Luedde,et al.  Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. , 2007, Cancer cell.

[62]  D. Gumucio,et al.  cis Elements of the Villin Gene Control Expression in Restricted Domains of the Vertical (Crypt) and Horizontal (Duodenum, Cecum) Axes of the Intestine* , 2002, The Journal of Biological Chemistry.

[63]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[64]  Klaus Rajewsky,et al.  NEMO/IKKγ-Deficient Mice Model Incontinentia Pigmenti , 2000 .

[65]  C. Kellendonk,et al.  Hepatocyte‐specific expression of Cre recombinase , 2000, Genesis.

[66]  G. Courtois,et al.  NEMO/IKK gamma-deficient mice model incontinentia pigmenti. , 2000, Molecular cell.

[67]  Stefan Grimm,et al.  The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal , 1998 .

[68]  P. Leder,et al.  The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. , 1998, Immunity.

[69]  H. Savelkoul,et al.  Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm). , 1996, The American journal of pathology.